KIR3DL2: Acute ATL Typing & Potential Therapeutic Target
The lymphoid tumor known as adult T-cell leukemia (ATL) is brought on by human T-cell leukemia...
Read MoreOct 18, 2022
The lymphoid tumor known as adult T-cell leukemia (ATL) is brought on by human T-cell leukemia...
Read MoreOct 18, 2022
Vacuoles, E1 ubiquitin-activating enzyme, X-linked, autoinflammatory somatic (VEXAS) syndrome, an...
Read MoreOct 18, 2022
The reversible P2Y12 inhibitor ticagrelor was compared to a placebo in phase 3 HESTIA3 research to...
Read MoreOct 18, 2022
MONDAY, Oct. 17, 2022 (HealthDay News) — From 2005 to 2020, Black women had less access to...
Read MoreOct 18, 2022
Glucocorticoid-induced TNF receptor-related protein (GITR) is the target of the monoclonal...
Read MoreOct 18, 2022
Safety and efficacy of the oral bromodomain and extraterminal inhibitor GS-5829, both alone and in...
Read MoreOct 17, 2022
In PNOC003, children and young people with a recent diagnosis of diffuse intrinsic pontine glioma...
Read MoreOct 17, 2022
Although toxicity and resistance have restricted ibrutinib’s application, the drug has...
Read MoreOct 17, 2022
The topic of cancer immunology has seen a surge of attention in recent years because of the...
Read MoreOct 17, 2022
Developments in the understanding of T-cell biology and immune-tumor cell interactions have...
Read MoreOct 15, 2022
FRIDAY, Oct. 14, 2022 (HealthDay News) — For childhood cancer survivors, the rates of...
Read MoreOct 14, 2022
FRIDAY, Oct. 14, 2022 (HealthDay News) — People with disabilities are commonly excluded from...
Read MoreOct 14, 2022
Minimal residual disease (MRD) assessment has emerged as an important indicator of therapy...
Read MoreOct 14, 2022
THURSDAY, Oct. 13, 2022 (HealthDay News) — In 2021, 37.0 percent of adults used telemedicine...
Read MoreOct 14, 2022
In several malignancies, the likelihood of death has been predicted using systemic inflammation...
Read MoreOct 14, 2022
Leptomeningeal metastasis (LM) is difficult to diagnose. CEACAM6 mRNA was discovered to be...
Read MoreOct 14, 2022
After first-line platinum-based chemotherapy fails, patients with small-cell lung cancer (SCLC)...
Read MoreOct 14, 2022
Advanced non-small cell lung cancer (NSCLC) patients are a diverse group with limited life...
Read MoreOct 13, 2022
WEDNESDAY, Oct. 12, 2022 (HealthDay News) — Patients with inflammatory breast cancer (IBC),...
Read MoreOct 12, 2022
TUESDAY, Oct. 11, 2022 (HealthDay News) — Adherence to annual screening among persons...
Read More